Amgen Cancer Drug Kyprolis Failure Is Not the End of the Road

August 14, 2014 8:51 AM

30 0

While early clinical trials of Amgen’s new cancer drug all passed without incident, Kyprolis failed a trial today. That could mean more than just returning to the drawing board.

All that matters when it comes to cancer treatments is how long a patient can live with the disease without concern for it progressing to a more progressive stage. This is precisely why Kyprolis has been available in the United States for the past two years: because during a phase 2 examination 23 p...

Read more

To category page